Skip to Content

GLYCERIN SUPPOSITORIES BP 2G CHILDRENS SIZE

Active substance: GLYCEROL

View full screen / Print PDF » Download PDF ⇩
Transcript
61 x 25 x 115mm

Keyline (Does not print)

OCRB

Proof No.

1

Braille

Zapf Dingbats

e

z

i

s

s

t

no.

2

c

h

'

i

n

e

r

MHRA/IMB
submission Yes
required

A

Reason for
Change

Addition of reporting of side
effects statement

Suf fix

14.10.2014

Date
s

Approved by
Date

gill.kennedy

When you sign this proof you are signifying full approval of
the Braille text and specification.

Issued by
Date

PCP Header Box

12
2g Children’s Size (Glycerol)

Glycerin Suppositories
12

5 011309 061215

For the relief of occasional constipation

glycerin
suppositories
Glycering
b
Suppositories
children
2g Children’s Size (Glycerol) s size
12
2g Children’s Size (Glycerol)

Glycerin Suppositories
Possible side effects

Dimensions

g

o

Read all the carton before use.
What the medicine is for

Helvetica Neue
p

Glycerin Suppositories relieve occasional constipation by
helping to stimulate bowel movement.

Helvetica LT

Process Black
p

Before you use Glycerin Suppositories

Process Yellow

22467509
u

✗ Do not use the medicine if your child has….

12's

IG Code
s

e

i

r

s

• An allergy to any of the ingredients.
• Do not use for adults or infants under 1 year old.

Storing the medicine

Pack Size
n

o

i

May cause bowel irritation, and occasionally abdominal
cramps. If your child has any side effects, stop use and tell
your doctor or pharmacist.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist
or nurse. This includes any possible side effects not listed
in this leaflet. You can also report side effects directly via
the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more
information on the safety of this medicine.

Helvetica
r

d

✓ How to use the medicine

Do not store above 25°C. Store in a dry place.
KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.
Use by the date shown on the side of the carton.
Active ingredient per suppository: glycerol 1.4g.
Also contains: gelatin and purified water.
MA holder and manufacturer: Thornton and Ross Ltd.,
Huddersfield, HD7 5QH, UK.
Text revised: October 2014
PL 00240/6101R
22467509

Process Magenta
e

l

• Suppositories must not be taken by mouth.
• Wash your hands before and after use.
• Remove the protective film before use by tearing the strip
at the notch or by cutting around the suppository.
• Dip the suppository in water and insert into the rectum.
Children: Insert one suppository as required.
Do not use for adults or infants under 1 year old.
If symptoms persist ask your doctor for advice.
some see a doctor straight away.

! Not to be swallowed. If anyone accidentally swallows

Carton
c

11581

This Braille is set to the Marburg Medium format unless you
have requested otherwise.

Component
y

CRN

There is no single European Braille authority and there are
many different Braille formats in existence, with country
specific characters.

Process Cyan

Braille BQ

l

Artwork No 536459

Whilst extreme care is taken in the setting of Braille, the
customer must take the final responsibility for its accuracy.

Glycerin Suppositories 2g Children's

g

Operator

Braille Warning! Chesapeake cannot accept responsibility
for any errors in this proof after approval by the customer.

Product
Title

glycerin
suppositories
b g
children s size

i

MHRA Header Box

Fonts Used
Colours Used

BRAILLE READS

LOT, MAN & EXP
Overprint area

12

2g Children’s Size (Glycerol)

Glycerin Suppositories

2g Children’s Size (Glycerol)

Glycerin Suppositories
12

MHRA Header Box
Product Title

Colours Used

Care Glycerin Suppositories BP 2g
Children's size

Component

Printed Laminate

Pack Size

12's

PCP No.

23396802

RM No.

233968

Dimensions

105mm x 61mm

Proof No.

1

Process Black

30.01.2013

23396802

23396802

23396802

23396802

Date

Keyline (Does not print)

PCP Header Box
Printer

Sarong

RMS No.

Approved by

Date

1771

Issued by

Date

Operator
Artwork No
CRN
Reason for
Change

system.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide